New Cox-2 studies

Yesterday two new studies were released on the Cox-2 class of drugs.  Both studies involved Cox-2 drugs taken in combination with other treatments.  They found in both cases that there were cardiovascular problems, including a worsening of hardening of the arteries (in mice) and an increased occurrence of heart attack and stroke (in humans).

When these results are combined with the results of previous tests, things look even worse.  As countries around the world take another look at this class of drugs and try to decide what to do, things are looking worse and worse for the likes of Bextra and Celebrex.